Kumar Rajeev, Yeh Jenny J, Fernandez Dennis, Hansen Nels
Fernandez & Associates LLP, Menlo Park, California 94025, USA.
J Biomol Screen. 2007 Sep;12(6):769-74. doi: 10.1177/1087057107305828.
Stem cell research and the intellectual property derived from it, because of its potential to completely transform health care, demand an especially high level of consideration from business and patent prosecution perspectives. As with other revolutionary technologies, ordinary risks are amplified (e.g., litigation), and ordinarily irrelevant considerations may become important (e.g., heightened level of both domestic and foreign legislative risk). In the first part of this article, general strategies for patent prosecutors such as several prosecution considerations and methods for accelerating patent prosecution process are presented. In the second part, patent prosecution challenges of stem cell-related patents and possible solutions are discussed. In the final part, ethical and public policy issues particular to stem cell-related and other biotechnological inventions are summarized.
干细胞研究及其衍生的知识产权，因其具有彻底改变医疗保健的潜力，从商业和专利审查的角度来看，需要格外高度的关注。与其他革命性技术一样，普通风险被放大了（例如诉讼），通常无关紧要的因素可能变得至关重要（例如国内外立法风险的加剧）。在本文的第一部分，介绍了专利审查人员的一般策略，如一些审查考虑因素和加速专利审查过程的方法。在第二部分，讨论了干细胞相关专利的审查挑战及可能的解决方案。在最后一部分，总结了干细胞相关及其他生物技术发明所特有的伦理和公共政策问题。
